Hypoglycemia clinical trials

Explore recruiting hypoglycemia clinical trials.

Recruiting hypoglycemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypoglycemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia in people with and without diabetes

Austria

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism

Denmark, Spain, Greece, Bulgaria, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intraclass safety and efficacy comparison among SGLT-2 inhibitors in elderly patients with type 2 diabetes. A pragmatic, phase IV, multicenter, open-label, randomised controlled trial.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes

Romania, Germany, Belgium, France

Therapeutic use (Phase IV) EU CTIS Study details

An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Multiple Ascending Dose, Open-label, Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of HM15136 Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) (ACHIEVE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Hypoglycemia trials by city

Hypoglycemia in Toronto Hypoglycemia in Vancouver Hypoglycemia in Montreal Hypoglycemia in Calgary Hypoglycemia in Edmonton Hypoglycemia in Ottawa Hypoglycemia in Winnipeg Hypoglycemia in Quebec City Hypoglycemia in Hamilton Hypoglycemia in Kitchener Hypoglycemia in London Hypoglycemia in Halifax Hypoglycemia in New York Hypoglycemia in Los Angeles Hypoglycemia in Chicago Hypoglycemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease